FIELD: medicine.
SUBSTANCE: using the reversed-phase high-performance liquid chromatography method with detection on a quadrupole tandem mass spectrometer with ionization in electrospray in the positive ion scan mode, after taking the drug at a dose of 0.5 mg, the cabergoline concentration in the patient's blood plasma is determined. With an increase in drug concentration after taking in 240 minutes, the need to continue conservative cabergoline therapy is identified. In the absence of cabergoline concentration growth dynamics in blood, alternative methods of treatment are used.
EFFECT: invention allows to form a personalized approach to the treatment of patients with partially resistant prolactin-secreting adenomas of the pituitary gland, to identify candidate patients as soon as possible to perform operative treatment, to avoid the development of complications due to ineffective therapy.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PITUITARY INCIDENTALOMA | 2023 |
|
RU2822656C1 |
| TREATMENT OR PREVENTION OF OVARY HYPERSTIMULATION SYNDROME (OHSS) WITH APPLICATION OF DOPHAMINE AGONIST | 2006 |
|
RU2416410C2 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2732251C1 |
| VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS | 2009 |
|
RU2528892C2 |
| METHOD OF PREDICTING DEVELOPMENT OF HYPOPITUITARISM IN PITUITARY MACROADENOMAS | 2022 |
|
RU2814774C2 |
| TREATMENT METHOD | 2006 |
|
RU2397778C2 |
| METHOD OF DIAGNOSING HORMONALLY INACTIVE MICROADENOMAS OF HYPOPHYSIS IN GIRLS | 2007 |
|
RU2351934C1 |
| DIAGNOSTIC TECHNIQUE FOR MRT-NEGATIVE ACTH-PRODUCING ADENOMAS OF HYPOPHYSIS | 2018 |
|
RU2699218C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING HYPERPROLACTINEMIA IN WOMEN WITH SCHIZOPHRENIA TAKING ANTIPSYCHOTIC THERAPY | 2023 |
|
RU2810398C1 |
| METHOD FOR DIAGNOSING PRIMARY HYPERPROLACTINEMIC HYPOGONADISM | 2001 |
|
RU2212036C1 |
